Peptide record

TPDB07292

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07292
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 CPPsite3.0 ToxinPred 3.0
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFDIIKKIAESF
Physicochemical Analysis
C71H113N15O19
RNCQHMPTWYV
I
1480.77
6.99
2
2
7
-0
1.45
0.669
127.69
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
1
A
0
R
0
N
1
D
0
C
1
E
0
Q
1
G
0
H
3
I
1
L
2
K
0
M
2
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 3 L: 1 K: 2 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13
C71H113N15O19
1480.77
6.99
-0
1.45
0.669
Evidence Records 63 records
Evidence 1 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

B. cereus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 2 Activity

Activity

MIC
Antibacterial
>100 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. mult
Evidence 3 Activity

Activity

MIC
Antibacterial
12 µg/mL

Target

L. lactis

Source & Reference

dbAMP DRAMP

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S.
Evidence 4 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP DRAMP

Other

ive against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. ep
Evidence 5 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP

Other

00 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), a
Evidence 6 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

P. multocida

Source & Reference

dbAMP DRAMP

Other

ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (B
Evidence 7 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006)
Evidence 8 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

g/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus
Evidence 9 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

S. uberis

Source & Reference

dbAMP DRAMP

Other

. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E
Evidence 10 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

S.aureus ATCC 25923

Source & Reference

dbAMP DRAMP

Other

0 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATC
Evidence 11 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Enterococcus faecalis PCM 2673

Source & Reference

dbAMP DRAMP

Other

) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans A
Evidence 12 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 13 Activity

Activity

MIC
Antibacterial
256 µg/mL

Target

P.aeruginosa ATCC 9027

Source & Reference

dbAMP DRAMP

Other

(MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 14 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

Candida albicans ATCC 10231

Source & Reference

dbAMP DRAMP

Other

MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 15 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

B. cereus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 16 Activity

Activity

MIC
Antifungal
>100 µg/mL

Target

E.coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. mult
Evidence 17 Activity

Activity

MIC
Antifungal
12 µg/mL

Target

L. lactis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S.
Evidence 18 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ive against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. ep
Evidence 19 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

00 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), a
Evidence 20 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

P. multocida

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (B
Evidence 21 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006)
Evidence 22 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

g/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus
Evidence 23 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

S. uberis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E
Evidence 24 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

S.aureus ATCC 25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

0 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATC
Evidence 25 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

Enterococcus faecalis PCM 2673

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans A
Evidence 26 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 27 Activity

Activity

MIC
Antifungal
256 µg/mL

Target

P.aeruginosa ATCC 9027

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 28 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

Candida albicans ATCC 10231

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 29 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

B. cereus

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 30 Activity

Activity

MIC
Antiparasitic
>100 µg/mL

Target

E.coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. mult
Evidence 31 Activity

Activity

MIC
Antiparasitic
12 µg/mL

Target

L. lactis

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S.
Evidence 32 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP 3.0 DRAMP

Other

ive against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. ep
Evidence 33 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP

Other

00 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), a
Evidence 34 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

P. multocida

Source & Reference

dbAMP 3.0 DRAMP

Other

ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (B
Evidence 35 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP

Other

ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006)
Evidence 36 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP

Other

g/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus
Evidence 37 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

S. uberis

Source & Reference

dbAMP 3.0 DRAMP

Other

. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E
Evidence 38 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

S.aureus ATCC 25923

Source & Reference

dbAMP 3.0 DRAMP

Other

0 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATC
Evidence 39 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

Enterococcus faecalis PCM 2673

Source & Reference

dbAMP 3.0 DRAMP

Other

) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans A
Evidence 40 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 41 Activity

Activity

MIC
Antiparasitic
256 µg/mL

Target

P.aeruginosa ATCC 9027

Source & Reference

dbAMP 3.0 DRAMP

Other

(MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 42 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

Candida albicans ATCC 10231

Source & Reference

dbAMP 3.0 DRAMP

Other

MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 43 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

B. cereus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 44 Activity

Activity

MIC
Antiviral
>100 µg/mL

Target

E.coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. mult
Evidence 45 Activity

Activity

MIC
Antiviral
12 µg/mL

Target

L. lactis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S.
Evidence 46 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ive against B. cereus (MIC 100 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. ep
Evidence 47 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

00 ug/ml), E.coli (MIC >100 ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), a
Evidence 48 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

P. multocida

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ug/ml), L. lactis (MIC 12 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (B
Evidence 49 Activity

Activity

MIC
Antiviral
50 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006)
Evidence 50 Activity

Activity

MIC
Antiviral
50 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

g/ml), M. luteus (MIC 100 ug/ml), P. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus
Evidence 51 Activity

Activity

MIC
Antiviral
50 µg/mL

Target

S. uberis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

. multocida (MIC 100 ug/ml), S. aureus (MIC 50 ug/ml), S. epidermidis (MIC 50 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E
Evidence 52 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

S.aureus ATCC 25923

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

0 ug/ml), and S. uberis (MIC 50 ug/ml) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATC
Evidence 53 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

Enterococcus faecalis PCM 2673

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

) (Boland and Separovic, 2006) . Also Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans A
Evidence 54 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against S.aureus ATCC 25923 (MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 55 Activity

Activity

MIC
Antiviral
256 µg/mL

Target

P.aeruginosa ATCC 9027

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(MIC 128 ug/ml), E. faecalis PCM 2673 (MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 56 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

Candida albicans ATCC 10231

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

MIC 64 ug/ml), E. coli ATCC 25922 (MIC 64 ug/ml), P.aeruginosa ATCC 9027 (MIC 256 ug/ml), C. albicans ATCC 10231 (MIC 32 ug/ml).
Evidence 57 Activity

Activity

62% Cytotoxicity
Toxicity
1000 µg/mL
Cytotoxic
62% Cytotoxicity | 1000 | µg/mL | target cell: Human skin fibroblasts

Target

Human skin fibroblasts

Source & Reference

NA
DBAASP
AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity. | J Pept Sci | 2019
Evidence 58 Activity

Activity

IC50
Toxicity
>700.145 µg/mL
Cytotoxic
IC50 | >700.145 | µg/mL | target cell: Human skin fibroblasts

Target

Human skin fibroblasts

Source & Reference

NA
DBAASP
AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity. | J Pept Sci | 2019
Evidence 59 Activity

Activity

19.38% Hemolysis
Toxicity
1000 µg/mL
Hemolytic Cytotoxic
19.38% Hemolysis | 1000 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity. | J Pept Sci | 2019
Evidence 60 Activity

Activity

50% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
50% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells. | Amino Acids | 2013
Evidence 61 Activity

Activity

5% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and characterization of new antimicrobial peptides derived from aurein 1.2 with enhanced antibacterial activity. | Biochimie | 2021
Evidence 62 Activity

Activity

39.96% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
39.96% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and characterization of new antimicrobial peptides derived from aurein 1.2 with enhanced antibacterial activity. | Biochimie | 2021
Evidence 63 Activity

Activity

LC50
Toxicity
200 µg/mL
Cytotoxic
LC50 | 200 | µg/mL | target cell: Human dermal fibroblasts

Target

Human dermal fibroblasts

Source & Reference

NA
DBAASP
Design and characterization of new antimicrobial peptides derived from aurein 1.2 with enhanced antibacterial activity. | Biochimie | 2021